• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia

    Thumbnail
    View/ Open
    Article (2.490Mb)

    Show full item record
    Author
    McCubrey, James A.
    URI
    http://hdl.handle.net/10342/9592
    Subject
     T lymphocytes; PI3K/Akt/mTOR signaling; T-acute lymphoblastic leukemia 
    Date
    2016-08-23
    Citation:
    APA:
    McCubrey, James A.. (August 2016). Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia. , (), - . Retrieved from http://hdl.handle.net/10342/9592

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    McCubrey, James A.. "Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia". . . (), August 2016. February 01, 2023. http://hdl.handle.net/10342/9592.
    Chicago:
    McCubrey, James A., "Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia," , no. (August 2016), http://hdl.handle.net/10342/9592 (accessed February 01, 2023).
    AMA:
    McCubrey, James A.. Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia. . August 2016; (): . http://hdl.handle.net/10342/9592. Accessed February 01, 2023.
    Collections
    • Microbiology and Immunology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback